Addus HomeCare Corporation (NASDAQ:ADUS) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Addus HomeCare Corporation (NASDAQ:ADUSGet Free Report) have received an average rating of “Moderate Buy” from the eleven research firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, seven have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $130.8750.

A number of analysts have weighed in on the company. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Barclays increased their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research report on Wednesday, July 8th. Royal Bank Of Canada upped their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research note on Wednesday. Finally, Citizens Jmp reaffirmed a “market outperform” rating and set a $142.00 price target on shares of Addus HomeCare in a report on Monday, May 18th.

Check Out Our Latest Analysis on ADUS

Insider Activity

In related news, insider Heather Brianne Dixon sold 288 shares of Addus HomeCare stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the sale, the insider directly owned 44,371 shares in the company, valued at $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 788 shares of company stock worth $73,506 over the last quarter. Corporate insiders own 4.10% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

Several large investors have recently bought and sold shares of the business. Oregon Public Employees Retirement Fund increased its stake in shares of Addus HomeCare by 2.5% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock worth $446,000 after purchasing an additional 103 shares during the period. ProShare Advisors LLC lifted its holdings in shares of Addus HomeCare by 3.1% during the fourth quarter. ProShare Advisors LLC now owns 3,527 shares of the company’s stock worth $379,000 after buying an additional 105 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its position in shares of Addus HomeCare by 0.6% in the second quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock valued at $2,150,000 after acquiring an additional 106 shares during the period. State of Wyoming grew its stake in shares of Addus HomeCare by 25.7% in the fourth quarter. State of Wyoming now owns 523 shares of the company’s stock valued at $56,000 after acquiring an additional 107 shares in the last quarter. Finally, Pathstone Holdings LLC raised its stake in Addus HomeCare by 0.9% in the 3rd quarter. Pathstone Holdings LLC now owns 12,727 shares of the company’s stock worth $1,502,000 after purchasing an additional 112 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Stock Up 2.5%

Shares of ADUS opened at $116.46 on Thursday. The company has a quick ratio of 1.83, a current ratio of 1.69 and a debt-to-equity ratio of 0.05. The company has a 50-day moving average price of $103.02 and a two-hundred day moving average price of $101.52. The stock has a market cap of $2.17 billion, a price-to-earnings ratio of 20.43, a P/E/G ratio of 1.56 and a beta of 0.87. Addus HomeCare has a 12 month low of $87.95 and a 12 month high of $124.43.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.70 by $0.03. The company had revenue of $377.41 million for the quarter, compared to analyst estimates of $376.24 million. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The company’s revenue was up 8.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.49 EPS. Equities analysts predict that Addus HomeCare will post 6.24 EPS for the current fiscal year.

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Featured Articles

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.